Measuring Inflammation Markers in Patients Having Heart Rhythm Ablation
Studies inflammation markers and fat around the heart in adults with atrial fibrillation.
Plain-language title generated from the registry record
Registry title: Change in Inflammatory State in Patients Undergoing Transcatheter Ablation of Atrial Fibrillation
Key facts
- Where
- Milan, ItalySee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 85 years old?
Source: NCT05961865, who can take part
Where in Italy
- Fondazione IRCCS Cà Granda Ospedale Maggiore PoliclinicoMilan, ItalyTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
- Trial code
- NCT05961865
- Record updated
- 13 September 2023
- Original description
It is a non-pharmacological (biological), spontaneous observational study. The main objective is to evaluate the correlation between inflammation markers and local adiposity, clinical risk factors and their possible variation following an AF ablation procedureRead full original descriptionShow less
Change in Inflammatory State in Patients Undergoing Transcatheter Ablation of Atrial Fibrillation
It is a non-pharmacological (biological), spontaneous observational study. The main objective is to evaluate the correlation between inflammation markers and local adiposity, clinical risk factors and their possible variation following an AF ablation procedure
Inclusion: Paroxysmal or persistent AF; Patients undergoing ESC/ERAH(European Society of Cardiology/European Heart Rhythm Association) approved catheter ablation procedures; Aged between 18 and 85 years; Ability to provide informed consent for study participation.
Exclusion: Presence of left auricular thrombosis on pre-procedural transesophageal echocardiogram; Myocardial infarction or unstable angina or recent coronary artery bypass graft (<6 months); Significant co-morbidity, such as cancer, severe renal failure requiring dialysis, severe obstructive pulmonary disease, cirrhosis, with a life expectancy of less than 12 months; Left ventricular ejection fraction <30%; Age > 85 years or < 18 years; NYHA functional class IV; Presence of contraindications to the procedure; Inability to provide informed consent for study participation.